Beneficient BENF Q1 2026 Earnings Massive EPS Beat on Positive Net Income but Shares Slide IDT Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement CAAP Q1 2026 Earnings EPS Misses Consensus by 75 as Operating Costs Weigh CDP Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Modest Stock Decline Amkor Technology AMKR Q1 2026 Earnings EPS Beats Estimates Amid Mixed Demand Signals C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage